# The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition

> **NCT02942888** · NA · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 46 (actual)

## Conditions studied

- Mild Cognitive Impairment
- NAD

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide riboside
- **DIETARY_SUPPLEMENT:** Sugar Pill

## Key facts

- **NCT ID:** NCT02942888
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-30
- **Primary completion:** 2019-08-31
- **Final completion:** 2021-08-16
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2021-09-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02942888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02942888, "The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02942888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*